小分子 API 市场规模、份额和成长分析（按类型、製造商、应用、地区）：产业预测 (2024-2031)

2022年全球小分子API（小分子原料药）市场规模为1848.5亿美元，从2023年的1949亿美元扩大到2031年的2977.6亿美元，预计将以复合年增长率成长。将成长5.44%。

在慢性病盛行率上升以及药物发现和开发投资增加的推动下，全球小分子活性药物原料药（API）格局预计将显着增长。品牌药价格的飙升正在刺激学名药的转移，预计未来小分子原料药的需求将进一步增加。此外，API 合成技术的进步和小分子研究投资的增加正在为 API 供应商创造新的机会。对负担得起的癌症药物的需求不断增长预计也将刺激全球范围内的市场扩张。然而，製造流程复杂、製造成本高和严格的法律规范等挑战可能会阻碍未来的市场需求。儘管如此，对永续和连续製造实践的日益关注为公司在不断变化的市场环境中创新和取得成功提供了潜在的途径。这些因素的综合显示小分子原料药产业的未来充满活力，并强调需要进行策略调整，以利用新出现的机会，同时克服固有的挑战。

目录

介绍

• 研究目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 二手资料来源和主要资料来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 母市场分析
• PESTEL分析
• 监管环境

小分子 API 市场：按类型

• 市场概况
• 合成
• 生物技术

小分子 API 市场：依製造商分类

• 市场概况
• 公司内部
• 外包

小分子 API 市场：依应用分类

• 市场概况
• 心臟病学
• 肿瘤学
• 中枢神经系统/神经病学
• 整形外科
• 内分泌学
• 呼吸系统医疗设备
• 胃肠病学
• 肾臟病学
• 眼科
• 其他的

小分子 API 市场：按地区

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲 (MEA)
  • 波湾合作理事会(GCC) 国家
  • 南非
  • 其他中东/非洲

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• 庄信万丰（英国）
• 辉瑞公司（美国）
• 南京金友生化製药有限公司 (中国)
• 赛诺菲公司（法国）
• 诺华公司（瑞士）
• 百时美施贵宝（美国）
• 勃林格殷格翰有限公司（德国）
• 葛兰素史克公司（英国）
• 吉利德科学公司（美国）
• 奥尔巴尼分子研究公司（美国）
• 阿斯特捷利康（英国）
• 默克公司（美国）
• BASF公司（德国）
• 梯瓦製药（以色列）
• 霍夫曼拉罗氏有限公司（瑞士）
• 雅宝公司（美国）
• 艾伯维（美国）
• Aurobindo Pharma（印度）
• Cambrex 公司（美国）
• 雷迪博士实验室有限公司（印度）
• 龙沙（瑞士）
• 默克公司（德国）
• 齐格飞控股公司（瑞士）
• 太阳製药工业有限公司（印度）

Global Small Molecule API Market size was valued at USD 184.85 billion in 2022 and is poised to grow from USD 194.90 billion in 2023 to USD 297.76 billion by 2031, growing at a CAGR of 5.44% in the forecast period (2024-2031).

The global landscape for small molecule active pharmaceutical ingredients (APIs) is poised for significant growth, driven by the rising prevalence of chronic diseases and increased investments in drug discovery and development. The soaring prices of branded medications are fueling a shift towards generic drugs, which is anticipated to further enhance the demand for small molecule APIs in the coming years. Additionally, advancements in API synthesis technologies and heightened investment in small molecule research present new opportunities for API suppliers. The escalating need for affordable oncology medications is also expected to stimulate market expansion on a worldwide scale. However, challenges such as the complexity of manufacturing processes, high production costs, and stringent regulatory frameworks may hinder market demand moving forward. Nonetheless, a growing focus on sustainable and continuous manufacturing methodologies offers potential avenues for small molecule API companies to innovate and thrive in the evolving market landscape. This convergence of factors signals a dynamic future for the small molecule API sector, emphasizing the need for strategic adaptations to leverage emerging opportunities while navigating inherent challenges.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Small Molecule Api market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Small Molecule Api Market Segmental Analysis

Global Small Molecule API Market is segmented on the type, manufacturer, application, and region. By type, the market is segmented into Synthetic and Biotech. By manufacturer, the market is segmented into In-house and Outsourced. By application, the market is segmented into Cardiology, Oncology, CNS and Neurology, Orthopedic, Endocrinology, Pulmonology, Gastroenterology, Nephrology, Ophthalmology, and Others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Driver of the Global Small Molecule Api Market

The rising prevalence of chronic disorders attributable to poor lifestyle choices is a significant market driver for the Global Small Molecule API market. As an increasing number of individuals grapple with conditions such as diabetes, cardiovascular diseases, and obesity, the demand for effective pharmaceutical interventions continues to surge. This growing need for targeted therapies propels the production and utilization of small molecule active pharmaceutical ingredients (APIs), known for their efficacy in treating a wide range of ailments. Consequently, the sustained expansion of healthcare expenditures and a focus on innovative drug development strategies further reinforce the momentum of the small molecule API market globally.

Restraints in the Global Small Molecule Api Market

The Global Small Molecule API market faces significant restraints due to the high manufacturing costs associated with the production of small molecule APIs. The process necessitates specialized equipment and facilities, which demand substantial capital investment. Additionally, the requirement for skilled professionals to operate such equipment further escalates operational costs. The reliance on expensive raw materials compounds these financial burdens, ultimately limiting the ability of manufacturers to scale production competitively. This cost-intensive aspect not only hinders market entry for new players but also restricts expansion opportunities for existing companies, thereby stifling overall market growth and development potential.

Market Trends of the Global Small Molecule Api Market

The Global Small Molecule API market is increasingly influenced by the rise of personalized medicine, driving a significant market trend towards tailored therapeutic solutions. As healthcare transitions to individualized treatment plans, small molecule API providers are optimizing their business models to address specific patient needs and niche markets. This shift is facilitating the development of innovative small molecule APIs that target unique biomarkers and genetic profiles, promising substantial returns for industry players. Consequently, this trend not only enhances treatment efficacy but also positions companies to thrive in a competitive landscape, thereby shaping the future of the pharmaceutical industry.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Parent Market Analysis
• PESTEL Analysis
• Regulatory Landscape

Small Molecule API Market, By Type

• Market Overview
• Synthetic
• Biotech

Small Molecule API Market, By Manufacturer

• Market Overview
• In-house
• Outsourced

Small Molecule API Market, By Application

• Market Overview
• Cardiology
• Oncology
• CNS and Neurology
• Orthopedic
• Endocrinology
• Pulmonology
• Gastroenterology
• Nephrology
• Ophthalmology
• Others

Small Molecule API Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Johnson Matthey (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nanjing King-Friend Biochemical Pharmaceutical Co. Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bristol-Myers Squibb (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GILEAD Sciences Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Albany Molecular Research Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co. Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BASF SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceuticals (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Albemarle Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aurobindo Pharma (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cambrex Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siegfried Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments